Table 1.
F→M HCT patient characteristics
| Characteristic | n |
| Total subjects | 28 |
| Primary disease | |
| Acute myelogenous leukemia | 10 |
| Non-Hodgkin lymphoma | 4 |
| Acute lymphoblastic leukemia | 3 |
| Chronic lymphocytic leukemia | 3 |
| Chronic myelogenous leukemia | 3 |
| Other | 5 |
| Age, median (range), y | 54 (21–65) |
| Conditioning regimen | |
| Myeloablative | 13 (46%) |
| Nonmyeloablative | 15 (54%) |
| Donor | |
| Related | 16 (57%) |
| Unrelated | 12 (43%) |
| cGVHD | |
| None | 8 (29%) |
| Mild | 3 (11%) |
| Moderate | 12 (43%) |
| Severe | 5 (17%) |
| aGVHD | |
| Grade II–IV | 9 (32%) |
| None–grade I | 19 (68%) |
| Survival, median (range), y | 3.2 y (1–5.9) |